On vaccine efficacy and reproduction numbers.

We consider the impact of a vaccination programme on the transmission potential of the infection in large populations. We define a measure of vaccine efficacy against transmission which combines the possibly random effect of the vaccine on individual susceptibility and infectiousness. This definition extends some previous work in this area to arbitrarily heterogeneous populations with one level of mixing, but leads us to question the usefulness of the concept of vaccine efficacy against infectiousness. We derive relationships between vaccine efficacy against transmission, vaccine coverage and reproduction numbers, which generalize existing results. In particular we show that the projected reproduction number RV does not depend on the details of the vaccine model, only on its overall effect on transmission. Explicit expressions for RV and the basic reproduction number R0 are obtained in a variety of settings. We define a measure of projected effectiveness of a vaccination programme PE=1-(RV/R0) and investigate its relationship with efficacy against transmission and vaccine coverage. We also study the effective reproduction number Re(t) at time t. Monitoring Re(t) over time is an important aspect of programme surveillance. Programme effectiveness PE is less sensitive than RV or the critical vaccination threshold to model assumptions. On the other hand Re(t) depends on the details of the vaccine model.

[1]  N G Becker,et al.  The effect of random vaccine response on the vaccination coverage required to prevent epidemics. , 1998, Mathematical biosciences.

[2]  K Dietz,et al.  Proportionate mixing models for age-dependent infection transmission , 1985, Journal of mathematical biology.

[3]  M E Halloran,et al.  Interpretation and estimation of vaccine efficacy under heterogeneity. , 1992, American journal of epidemiology.

[4]  M. Halloran,et al.  Design and interpretation of vaccine field studies. , 1999, Epidemiologic reviews.

[5]  S. Utev,et al.  The effect of community structure on the immunity coverage required to prevent epidemics. , 1998, Mathematical biosciences.

[6]  C. Farrington,et al.  Estimation of Waning Vaccine Efficacy , 2002 .

[7]  M E Halloran,et al.  Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. , 1998, Statistics in medicine.

[8]  K. Dietz.  The estimation of the basic reproduction number for infectious diseases , 1993, Statistical methods in medical research.

[9]  P G Smith,et al.  Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. , 1984, International journal of epidemiology.

[10]  M. Halloran,et al.  Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines. , 1998, American journal of epidemiology.

[11]  P E Fine,et al.  Herd immunity: history, theory, practice. , 1993, Epidemiologic reviews.

[12]  M E Halloran,et al.  Study designs for evaluating different efficacy and effectiveness aspects of vaccines. , 1997, American journal of epidemiology.

[13]  C. P. Farrington,et al.  Estimation of the basic reproduction number for infectious diseases from age‐stratified serological survey data , 2001 .

[14]  N G Becker,et al.  Immunization levels for preventing epidemics in a community of households made up of individuals of various types. , 1996, Mathematical biosciences.

[15]  J. Wallinga,et al.  Estimation of measles reproduction ratios and prospects for elimination of measles by vaccination in some Western European countries , 2001, Epidemiology and Infection.

[16]  O. Diekmann,et al.  On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations , 1990, Journal of mathematical biology.

[17]  C P Farrington,et al.  Epidemiology of transmissible diseases after elimination. , 2000, American journal of epidemiology.

[18]  M E Halloran,et al.  Direct and indirect effects in vaccine efficacy and effectiveness. , 1991, American journal of epidemiology.

[19]  Sally M. Blower,et al.  Imperfect vaccines and herd immunity to HIV , 1993, Proceedings of the Royal Society of London. Series B: Biological Sciences.